Peak Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Peak Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,828	Closed	-$1.28M	–	80
2021 Q4	$1.28M	Buy	20,828 +3,552	+21%	+$246K	0.98%	30
2021 Q3	$1.29M	Buy	17,276 +1,069	+7%	+$89.7K	1.14%	28
2021 Q2	$1.5M	Buy	16,207 +2,172	+15%	+$185K	1.29%	31
2021 Q1	$1.25M	Sell	14,035 -15,964	-53%	-$1.58M	1.05%	37
2020 Q4	$2.8M	Buy	+29,999	New	+$2.39M	2.41%	11

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Peak Financial Advisors's ARKG Position: Q1 2022 in Review

Peak Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 20,828 shares — an estimated $1.28M sold.

Peak Financial Advisors first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $2.8M in Q4 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Peak Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Peak Financial Advisors sold 20,828 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $1.28M.
Peak Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
Peak Financial Advisors's ARK Genomic Revolution ETF position peaked at $2.8M in Q4 2020.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Peak Financial Advisors's 13F filing for Q1 2022, filed 22 Apr 2022.